test has been as the evidence based test to be used to confirm smoking
cessation in the “Quit to Win Challenge” being held in Quebec, Canada.
Once again, Mossman Associates’ NicCheck test has been chosen to be the evidence based test used to confirm smoking cessation in the “Quit to Win Challenge” being held in Quebec Canada. The 2016 edition of the “Quit to Win Challenge” annual campaign started on March 1st and will end on April 11th. After that time winners will be selected and tested as they have done in previous years using our NicCheck product.
“We are proud to continue our support of these types of contests”, quotes Donald Mossman, President of Mossman Associates.
He continues, “Competitions like these in Romania, Canada, and Taiwan are instrumental in helping people break the smoking habit. We look forward to working with other countries, universities and organizations that initiate on these types of programs”.
NicCheck is a dry chemistry dipstick for the semi-quantitative measurement of nicotine and nicotine metabolites in urine as an aid in the verification of a person’s true smoking status. This 15 minute test yields a semi-quantitative measurement of a person’s nicotine consumption based on the color intensity of the reaction found on the NicCheck test strips.
About Mossman Associates, Inc.
Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.